The incidence of heart failure (HF) is increasing and it remains the only area in cardiovascular disease wherein hospitalization rates and mortality have worsened in the past 25 years. This review discusses the roles of molecular imaging using positron emission tomography in HF, including perfusion, metabolism, viability, innervation, and inflammation, and provides new insights into the pathophysiology and therapeutic strategy of HF.